Patent
   D474536
Priority
Jan 07 2002
Filed
Jan 07 2002
Issued
May 13 2003
Expiry
May 13 2017

TERM.DISCL.
Assg.orig
Entity
unknown
52
3
n/a
The ornamental design for inhaler for dispensing medications, as shown and described.

FIG. 1 is a front perspective view.

FIG. 2 is a rear perspective view.

FIG. 3 is a front perspective view.

FIG. 4 is a right side view.

FIG. 5 is a left side view.

FIG. 6 is a top view; and,

FIG. 7 is a bottom view.

Patel, Rajan, Ng, Francis, Albulet, Paul, Maxwell, Joseph

Patent Priority Assignee Title
10130581, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
10130685, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
10130709, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
10143655, Sep 14 2005 MannKind Corporation Method of drug formulation
10159644, Oct 26 2012 MannKind Corporation; TechnoVax, Inc. Inhalable vaccine compositions and methods
10172850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
10201672, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
10258664, Oct 24 2011 MannKind Corporation Methods and compositions for treating pain
10307464, Mar 27 2015 MannKind Corporation Use of ultrarapid acting insulin
10342938, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
10421729, Mar 15 2013 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
10561806, Oct 02 2014 MannKind Corporation Mouthpiece cover for an inhaler
10625034, Apr 01 2011 MannKind Corporation Blister package for pharmaceutical cartridges
10675421, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
10751488, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
11446127, Aug 05 2013 MannKind Corporation Insufflation apparatus and methods
8424518, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8485180, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
8499757, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8636001, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8912193, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9192675, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9220687, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9233159, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9241903, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
9283193, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9339615, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9358352, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9364436, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
9364619, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
9393372, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
9446001, Sep 14 2005 MannKind Corporation Increasing drug affinity for crystalline microparticle surfaces
9446133, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9511198, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9610351, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9630930, Jun 12 2009 MannKind Corporation Diketopiperazine microparticles with defined specific surface areas
9655850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9662461, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9675674, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
9700690, Mar 20 2002 MannKind Corporation Inhalation apparatus
9706944, Nov 03 2009 MannKind Corporation Apparatus and method for simulating inhalation efforts
9717689, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9796688, Aug 20 2004 MannKind Corporation Catalysis of diketopiperazine synthesis
9801925, Jun 29 1999 MannKind Corporation Potentiation of glucose elimination
9802012, Jul 12 2012 MannKind Corporation Dry powder drug delivery system and methods
9925144, Jul 18 2013 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
9943571, Aug 11 2008 MannKind Corporation Use of ultrarapid acting insulin
9983108, Mar 11 2009 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
D579549, Jun 07 2007 Novartis AG Inhaler
D771798, Jun 17 2014 KONINKLIJKE PHILIPS N V Handheld respiratory device
D776254, Jun 17 2014 KONINKLIJKE PHILIPS N V Handheld respiratory device
D776255, Jun 17 2014 KONINKLIJKE PHILIPS N V Handheld respiratory device
Patent Priority Assignee Title
D326518, Nov 16 1988 HARRIS PHARMACEUTICAL LTD Inhalator
D350602, Nov 01 1991 RHONE-POULENC RORER LIMITED, A CORP OF GREAT BRITAIN Combined dry powder inhaler and cap
D437931, Oct 13 1999 SmithKline Beecham Corporation Inhalation device
////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jan 07 2002Aerogen, Inc.(assignment on the face of the patent)
Mar 27 2002MAXWELL, JOSEPHAEROGEN, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0128280601 pdf
Mar 27 2002NG, FRANCISAEROGEN, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0128280601 pdf
Mar 28 2002ALBULET, PAULAEROGEN, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0128280601 pdf
Mar 28 2002PATEL, RAJAN AEROGEN, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0128280601 pdf
Sep 08 2003AEROGEN, INC SF CAPITAL PARTNERS, LTD SECURITY AGREEMENT0144910108 pdf
May 13 2005SF CAPITAL PARTNERS LTD AEROGEN, INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0194190577 pdf
Dec 31 2008AEROGEN, INC Novartis Pharma AGASSIGNMENT OF PATENT RIGHTS0220620905 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule